Table 1 Clinical and biochemical features of healthy controls and patients with NASH.
From: CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
Factors | Healthy controls (n = 22) | NASH (n = 22) |
|---|---|---|
Female (n) | 14 | 11 |
Age (years) | 50.30 ± 7.96 | 51.10 ± 11.47 |
BMI (kg/m2) | 21.6 ± 4.2 | 27.3 ± 5.1** |
ALT (UI/I) | 21.60 ± 10.37 | 132.70 ± 552.0** |
AST (UI/I) | 18.00 ± 5.08 | 62.90 ± 34.15** |
AKP (UI/I) | 86.00 ± 21.40 | 87.00 ± 16.2 |
GGT (UI/I) | 16.70 ± 10.70 | 93.22 ± 78.88* |
Total bilirubin (μmol/L) | 8.88 ± 4.23 | 13.22 ± 5.07 |
Conjugated bilirubin (μmol/L) | 3.66 ± 2.16 | 4.18 ± 1.52 |
